Pharmaceutical Representation
Building and managing professional relationships with international pharmaceutical manufacturers seeking reliable representation and structured market development in Iraq.
Al-Dawaa Al-Awwal Scientific Bureau is an Iraqi pharmaceutical scientific bureau established in 2024 and operating as a member of Amedia Group, a diversified pharmaceutical and healthcare business group in Iraq.
We are dedicated to developing long-term partnerships with international pharmaceutical manufacturers and supporting their business objectives through pharmaceutical representation, regulatory coordination, scientific promotion, and strategic market development.
By combining focused local engagement with the broader business experience and collaborative capabilities of Amedia Group, we aim to provide our partners with a reliable foundation for establishing and expanding their presence in the Iraqi pharmaceutical market.
Explore Our Expertise Become Our PartnerLocal Understanding. International Standards. Long-Term Partnerships.
Entering and developing a pharmaceutical market requires more than identifying commercial opportunities. It demands regulatory awareness, scientific credibility, a thorough understanding of local market dynamics, and a partner committed to sustainable business development.
At Al-Dawaa Al-Awwal Scientific Bureau, we approach pharmaceutical partnerships with these priorities in mind.
Our focus is to build professional relationships with reputable international manufacturers, facilitate regulatory and scientific activities, and develop commercially sound strategies tailored to the requirements of the Iraqi healthcare market.
We believe that successful partnerships are built on transparency, mutual commitment, professional accountability, and a shared vision for long-term growth.
Pharmaceutical Representation
Building and managing professional relationships with international pharmaceutical manufacturers seeking reliable representation and structured market development in Iraq.
Regulatory Affairs & Product Registration
Coordinating pharmaceutical registration activities, regulatory documentation, submissions, and communication with the relevant Iraqi health authorities.
Scientific Promotion
Supporting responsible, evidence-based pharmaceutical communication and professional engagement with healthcare practitioners.
Market Access & Business Development
Evaluating market opportunities, developing product-positioning strategies, and supporting sustainable commercial expansion.
Portfolio Development
Identifying pharmaceutical products and therapeutic opportunities aligned with market needs, regulatory feasibility, and long-term commercial potential.
The Focus of a Dedicated Scientific Bureau. The Strength of a Diversified Group.
Al-Dawaa Al-Awwal is a member of Amedia Group, an Iraqi pharmaceutical business group comprising scientific bureaus, pharmaceutical trading companies, and distribution operations.
This affiliation provides opportunities for collaboration, access to shared market knowledge, regulatory coordination, and strategic commercial planning.
For international pharmaceutical manufacturers, our group affiliation creates an opportunity to work with a dedicated scientific bureau within a wider pharmaceutical business environment.
Discover Amedia GroupWe welcome cooperation with international pharmaceutical manufacturers seeking to establish a presence in Iraq, develop new product portfolios, expand therapeutic coverage, or explore additional market opportunities.
Our objective is to establish mutually beneficial partnerships supported by professional communication, regulatory responsibility, commercial discipline, and a long-term strategic perspective.
Become Our Partner Contact UsAl-Dawaa Al-Awwal Scientific Bureau is an Iraqi pharmaceutical scientific bureau established in 2024 and operating as a member of Amedia Group, a diversified pharmaceutical and healthcare business group in Iraq.
We are dedicated to developing long-term partnerships with international pharmaceutical manufacturers and supporting their business objectives through pharmaceutical representation, regulatory coordination, scientific promotion, and strategic market development.
By combining focused local engagement with the broader business experience and collaborative capabilities of Amedia Group, we aim to provide our partners with a reliable foundation for establishing and expanding their presence in the Iraqi pharmaceutical market.
Explore Our Expertise Become Our PartnerLocal Understanding. International Standards. Long-Term Partnerships.
Entering and developing a pharmaceutical market requires more than identifying commercial opportunities. It demands regulatory awareness, scientific credibility, a thorough understanding of local market dynamics, and a partner committed to sustainable business development.
At Al-Dawaa Al-Awwal Scientific Bureau, we approach pharmaceutical partnerships with these priorities in mind.
Our focus is to build professional relationships with reputable international manufacturers, facilitate regulatory and scientific activities, and develop commercially sound strategies tailored to the requirements of the Iraqi healthcare market.
We believe that successful partnerships are built on transparency, mutual commitment, professional accountability, and a shared vision for long-term growth.
Pharmaceutical Representation
Building and managing professional relationships with international pharmaceutical manufacturers seeking reliable representation and structured market development in Iraq.
Regulatory Affairs & Product Registration
Coordinating pharmaceutical registration activities, regulatory documentation, submissions, and communication with the relevant Iraqi health authorities.
Scientific Promotion
Supporting responsible, evidence-based pharmaceutical communication and professional engagement with healthcare practitioners.
Market Access & Business Development
Evaluating market opportunities, developing product-positioning strategies, and supporting sustainable commercial expansion.
Portfolio Development
Identifying pharmaceutical products and therapeutic opportunities aligned with market needs, regulatory feasibility, and long-term commercial potential.
The Focus of a Dedicated Scientific Bureau. The Strength of a Diversified Group.
Al-Dawaa Al-Awwal is a member of Amedia Group, an Iraqi pharmaceutical business group comprising scientific bureaus, pharmaceutical trading companies, and distribution operations.
This affiliation provides opportunities for collaboration, access to shared market knowledge, regulatory coordination, and strategic commercial planning.
For international pharmaceutical manufacturers, our group affiliation creates an opportunity to work with a dedicated scientific bureau within a wider pharmaceutical business environment.
Discover Amedia GroupWe welcome cooperation with international pharmaceutical manufacturers seeking to establish a presence in Iraq, develop new product portfolios, expand therapeutic coverage, or explore additional market opportunities.
Our objective is to establish mutually beneficial partnerships supported by professional communication, regulatory responsibility, commercial discipline, and a long-term strategic perspective.
Become Our Partner Contact UsAL-DAWAA AL-AWWAL / WHY IRAQ
Iraq represents an important market for pharmaceutical manufacturers seeking opportunities in the Middle East.
The country’s healthcare sector encompasses public and private healthcare providers, hospitals, specialist clinics, community pharmacies, and a range of pharmaceutical distribution channels.
Opportunities exist across various therapeutic areas, supported by the continuing need for access to reliable pharmaceutical treatments and the development of healthcare services.
At the same time, successful market participation requires careful attention to the country’s regulatory framework, product registration procedures, pricing requirements, importation rules, and commercial conditions.
Regulatory Requirements
Pharmaceutical registration, product documentation, applicable approvals, and ongoing regulatory compliance are central to lawful market access.
Therapeutic Demand
Product opportunities should be assessed in relation to local healthcare needs, prescribing practices, and relevant therapeutic segments.
Commercial Positioning
Pricing considerations, competitive products, market segmentation, and sustainable demand planning are important elements of successful market development.
Local Coordination
Clear communication and reliable local representation can support the coordination of regulatory, scientific, and commercial activities.
Long-Term Planning
Pharmaceutical development requires realistic timelines, appropriate resources, and sustained cooperation between manufacturers and their local partners.
Selecting a suitable local partner is an important strategic consideration for international manufacturers.
A professional local representative can help manufacturers understand regulatory expectations, evaluate market opportunities, coordinate local activities, and develop structured commercial plans.
At Al-Dawaa Al-Awwal, we aim to contribute to these objectives through dedicated professional engagement and access to the collaborative business environment of Amedia Group.
Explore Partnership Opportunities in IraqAL-DAWAA AL-AWWAL / OUR EXPERTISE
The Iraqi pharmaceutical market presents opportunities for international manufacturers, alongside regulatory, operational, and commercial requirements that demand careful planning.
Al-Dawaa Al-Awwal Scientific Bureau focuses on the key activities necessary to support responsible pharmaceutical representation and sustainable market development.
We seek to establish and maintain long-term relationships with international pharmaceutical manufacturers interested in developing their commercial presence in Iraq.
Strategic partner engagement and coordination.
Understanding manufacturers’ commercial objectives.
Evaluating potential pharmaceutical portfolios.
Supporting market-entry and expansion planning.
Maintaining professional communication and business follow-up.
Our goal is to build relationships founded on mutual confidence, clearly defined expectations, and long-term commercial alignment.
Successful pharmaceutical market development requires careful consideration of applicable registration procedures and regulatory obligations.
Coordination of pharmaceutical registration requirements.
Review and follow-up of regulatory documentation.
Support for product registration and re-registration procedures.
Communication regarding regulatory updates and authority requests.
Coordination of product-related regulatory matters.
We recognize that regulatory requirements may evolve and that effective communication with manufacturers is essential to maintaining compliant and sustainable operations.
Scientific Credibility. Responsible Communication.
Effective pharmaceutical promotion must be supported by accurate product information, appropriate scientific communication, and professional interaction with healthcare practitioners.
We support the development of scientific promotional activities that reflect approved product information, applicable regulations, and responsible pharmaceutical practices. Our focus is to contribute to informed professional engagement while supporting the appropriate positioning of pharmaceutical products within their relevant therapeutic areas.
A successful market-entry strategy should reflect the regulatory environment, therapeutic demand, competitive positioning, and the commercial objectives of the manufacturing partner.
Assessment of potential market opportunities.
Evaluation of product positioning and competitive environments.
Identification of relevant therapeutic segments.
Commercial planning and demand assessment.
Exploration of portfolio expansion opportunities.
Strategic coordination with international partners.
We aim to help transform carefully evaluated market opportunities into commercially sustainable pharmaceutical partnerships.
Portfolio selection is an important component of sustainable pharmaceutical development.
We seek to identify products that respond to relevant healthcare needs and demonstrate appropriate regulatory feasibility and commercial potential. Our portfolio-development approach considers therapeutic relevance, market demand, competitive positioning, registration requirements, and long-term partnership objectives.
Through its affiliation with Amedia Group, Al-Dawaa Al-Awwal can explore opportunities for coordinated commercial and operational support within the group’s wider pharmaceutical business network.
Depending on the requirements of each partnership and the applicable regulatory framework, this may include coordination with relevant group entities involved in pharmaceutical trading and distribution activities. This approach allows pharmaceutical partnerships to be structured according to their specific operational and commercial requirements.
AL-DAWAA AL-AWWAL / CONTACT US
Thank you for your interest in Al-Dawaa Al-Awwal Scientific Bureau.
We welcome inquiries from international pharmaceutical manufacturers, business development professionals, healthcare industry organizations, and potential strategic partners.
Please contact us to discuss pharmaceutical representation, regulatory coordination, portfolio development, or potential business cooperation in Iraq.
CORPORATE CONTACT INFORMATION
AL-DAWAA AL-AWWAL SCIENTIFIC BUREAU
A Member of Amedia Group
Established in 2024
Head Office:
Muhandiseen, District 507, Street 28, House 7
Baghdad, Iraq
Telephone: +964 788 088 0200
Email: info@aldawaa-alawwal.com
Website: www.aldawaa-alawwal.com
SEND US AN INQUIRY — FORM FIELD LABELS
Full Name [required]
Company Name [required]
Country [required]
Corporate Email Address [required]
Area of Interest [dropdown]
Subject [required]
Your Message [required]
Button: Submit Inquiry
Confirmation and data processing must be implemented by the website developer.
We welcome professional inquiries and partnership proposals through our official communication channels.
Muhandiseen, District 507, Street 28, House 7
Baghdad, Iraq
AL-DAWAA AL-AWWAL / INTERNATIONAL PARTNERSHIPS
At Al-Dawaa Al-Awwal Scientific Bureau, we recognize that international pharmaceutical partnerships require a shared understanding of business objectives, regulatory responsibilities, market opportunities, and long-term expectations.
We welcome discussions with pharmaceutical manufacturers seeking professional representation and sustainable business development in Iraq.
Our partnership approach is built around regulatory awareness, scientific integrity, commercial planning, and transparent communication.
01 | Dedicated Local Representation
We aim to provide international manufacturers with a professional local point of contact for pharmaceutical representation and the coordination of relevant business activities.
02 | Understanding of the Iraqi Market
Our approach reflects the importance of local regulatory requirements, market conditions, and the commercial realities of pharmaceutical business development in Iraq.
03 | Regulatory Commitment
We recognize the importance of accurate documentation, structured regulatory coordination, and compliance with applicable pharmaceutical requirements.
04 | Strategic Market Development
We emphasize careful product evaluation, market positioning, commercial planning, and the identification of sustainable business opportunities.
05 | Amedia Group Affiliation
Our membership in Amedia Group provides opportunities to benefit from a broader pharmaceutical business network and collaborative industry experience.
06 | Long-Term Partnership Philosophy
We seek relationships built on transparency, reliability, mutual understanding, and long-term commercial objectives.
Pharmaceutical representation and distribution partnerships.
Product registration and regulatory coordination.
Introduction of new pharmaceutical products.
Development of additional therapeutic portfolios.
Scientific promotion and professional healthcare engagement.
Market-entry strategies and commercial expansion.
Long-term strategic business cooperation.
The specific scope of each partnership will be determined through mutual discussion, regulatory feasibility, operational requirements, and agreed commercial objectives.
01 | Understanding Your Portfolio
We begin by understanding the manufacturer’s products, therapeutic areas, market objectives, and partnership expectations.
02 | Evaluating Market Potential
We consider relevant regulatory, therapeutic, competitive, and commercial factors to assess potential opportunities.
03 | Defining the Cooperation Framework
We work toward establishing a clear understanding of the proposed responsibilities, regulatory activities, commercial objectives, and operational arrangements.
04 | Supporting Market Development
Following agreement and the applicable approvals, we seek to support coordinated implementation and sustained business development.
Whether your company is considering entering the Iraqi pharmaceutical market, introducing new products, or exploring opportunities for portfolio expansion, we welcome the opportunity to discuss potential cooperation.
AL-DAWAA AL-AWWAL / AMEDIA GROUP
One Group. Diverse Pharmaceutical Capabilities.
Al-Dawaa Al-Awwal Scientific Bureau is part of Amedia Group, a diversified Iraqi pharmaceutical and healthcare business group.
The group brings together companies and scientific bureaus engaged in pharmaceutical representation, regulatory affairs, trading, and distribution-related activities.
Its diversified business structure supports opportunities for cooperation, coordination, and the exchange of industry knowledge across its member entities.
Farabi Pharma Scientific Bureau
Amedia Group member entity
Razi Pharma Scientific Bureau
Amedia Group member entity
Mukhtar Scientific Bureau
Amedia Group member entity
Platinum Scientific Bureau
Amedia Group member entity
Al-Dawaa Al-Awwal Scientific Bureau
Amedia Group member entity
Waseet Drug Store
Amedia Group member entity
Amedia Company for General Trading
Amedia Group member entity
Itizan Company for General Trading
Amedia Group member entity
Our membership in Amedia Group offers opportunities for collaboration across relevant regulatory, scientific, commercial, and operational functions.
This broader environment supports knowledge exchange, coordinated business planning, and the identification of potential synergies within the pharmaceutical sector.
For international manufacturers, Al-Dawaa Al-Awwal provides a dedicated point of engagement within a diversified Iraqi pharmaceutical group.
Our aim is to combine focused professional representation with the advantages of long-term group affiliation.
Focused Representation. Broader Business Perspective. Sustainable Partnerships.
AL-DAWAA AL-AWWAL / ABOUT US
Established in 2024 and headquartered in Baghdad, Al-Dawaa Al-Awwal Scientific Bureau operates within Iraq’s pharmaceutical sector as a member of Amedia Group.
The bureau was established to support the development of professional pharmaceutical partnerships and facilitate the introduction and sustainable market development of quality pharmaceutical products in Iraq.
Our approach recognizes the importance of aligning international pharmaceutical standards with local regulatory requirements, healthcare priorities, and market conditions.
We seek to serve as a dependable local representative for pharmaceutical manufacturers through structured regulatory coordination, scientifically responsible promotional activities, and commercially focused business development.
As a member of Amedia Group, Al-Dawaa Al-Awwal maintains its distinct corporate identity while benefiting from the strategic environment, business experience, and collaborative framework of the wider group.
Our Vision
To become a trusted and respected pharmaceutical scientific bureau in Iraq, recognized for regulatory competence, scientific credibility, professional excellence, and enduring partnerships with international pharmaceutical manufacturers.
Our Mission
To connect international pharmaceutical manufacturers with opportunities in Iraq’s healthcare market through professional representation, regulatory coordination, responsible scientific engagement, and sustainable commercial development. We are committed to creating long-term value for our partners while contributing to the availability of quality pharmaceutical products for the Iraqi healthcare community.
Integrity & Transparency
We conduct business with honesty, accountability, and respect for the professional and regulatory responsibilities associated with the pharmaceutical sector.
Quality & Compliance
We recognize pharmaceutical quality, regulatory compliance, and responsible business conduct as fundamental requirements for sustainable growth.
Scientific Responsibility
We support accurate, evidence-based pharmaceutical information and ethical engagement with healthcare professionals.
Partnership & Trust
We seek to develop lasting relationships through transparent communication, mutual respect, and clearly defined business objectives.
Professional Excellence
We are committed to maintaining high professional standards and continuously strengthening our regulatory, scientific, and commercial approach.
Sustainable Development
We prioritize long-term business relationships, carefully selected opportunities, and balanced commercial growth.
Our long-term direction is centered on developing a well-structured pharmaceutical portfolio and establishing productive relationships with reputable international pharmaceutical manufacturers.
We focus on opportunities that align regulatory feasibility, therapeutic relevance, commercial sustainability, and the strategic objectives of our partners.
Through disciplined business development and collaboration within Amedia Group, we aim to strengthen our contribution to Iraq’s pharmaceutical sector.